Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function

Horm Metab Res. 2008 Jan;40(1):66-8. doi: 10.1055/s-2007-993217. Epub 2007 Dec 18.

Authors

D Pitocco¹, E DiStasio, A Crinò, S Manfrini, C Guglielmi, N Visalli, C Suraci, M C Matteoli, M G Cavallo, C Bizzarri, P Pozzilli; IMDIAB Group

Affiliation

¹ Universit à Cattolica, Rome, Italy.

PMID: 18085501
DOI: 10.1055/s-2007-993217

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Age of Onset
Aging / physiology*
C-Peptide / blood
Child
Child, Preschool
Diabetes Mellitus, Type 1 / diagnosis*
Diabetes Mellitus, Type 1 / drug therapy*
Diabetes Mellitus, Type 1 / pathology
Diabetes Mellitus, Type 1 / physiopathology
Female
Follow-Up Studies
Humans
Immunologic Factors / therapeutic use*
Insulin-Secreting Cells / metabolism*
Male

Substances

C-Peptide
Immunologic Factors